Real-life Experiences with CAR T-cell Therapy with Idecabtagene Vicleucel (Ide-Cel) for Triple-Class Exposed Relapsed/refractory Multiple Myeloma Patients
BMC Cancer（2023）
Key words
Myeloma,CAR-T,Relapsed,Outcome,Ide-cel
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined